<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">J Am Geriatr Soc</journal-id><journal-id journal-id-type="iso-abbrev">J Am Geriatr Soc</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Journal of the American Geriatrics Society</journal-title></journal-title-group><issn pub-type="ppub">0002-8614</issn><issn pub-type="epub">1532-5415</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11905919</article-id><article-id pub-id-type="pmcid-ver">PMC11905919.1</article-id><article-id pub-id-type="pmcaid">11905919</article-id><article-id pub-id-type="pmcaiid">11905919</article-id><article-id pub-id-type="manuscript-id">NIHMS2054154</article-id><article-id pub-id-type="pmid">38864591</article-id><article-id pub-id-type="doi">10.1111/jgs.19018</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS2054154</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA2054154</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Sustained IL-6 and sTNF-&#945;R1 levels after hip fracture predict 5-year mortality: A prospective cohort study from the Baltimore Hip Studies</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-3054-7213</contrib-id><name name-style="western"><surname>C&#226;mara</surname><given-names initials="SMA">Saionara M. A.</given-names></name><degrees>PhD</degrees><xref rid="A1" ref-type="aff">1</xref><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hochberg</surname><given-names initials="MC">Marc C.</given-names></name><degrees>MD, MPH</degrees><xref rid="A3" ref-type="aff">3</xref><xref rid="A4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Miller</surname><given-names initials="R">Ram</given-names></name><degrees>MD, CM, MS</degrees><xref rid="A5" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ryan</surname><given-names initials="AS">Alice S.</given-names></name><degrees>PhD</degrees><xref rid="A6" ref-type="aff">6</xref><xref rid="A7" ref-type="aff">7</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Orwig</surname><given-names initials="D">Denise</given-names></name><degrees>PhD</degrees><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gruber-Baldini</surname><given-names initials="AL">Ann L.</given-names></name><degrees>PhD</degrees><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Guralnik</surname><given-names initials="J">Jack</given-names></name><degrees>MD, PhD</degrees><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Magder</surname><given-names initials="LS">Laurence S.</given-names></name><degrees>PhD</degrees><xref rid="A8" ref-type="aff">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Feng</surname><given-names initials="Z">Zhaoyong</given-names></name><degrees>MS</degrees><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-9063-0617</contrib-id><name name-style="western"><surname>Falvey</surname><given-names initials="JR">Jason R.</given-names></name><degrees>DPT, PhD</degrees><xref rid="A2" ref-type="aff">2</xref><xref rid="A9" ref-type="aff">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Beamer</surname><given-names initials="BA">Brock A.</given-names></name><degrees>MD</degrees><xref rid="A6" ref-type="aff">6</xref><xref rid="A7" ref-type="aff">7</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Magaziner</surname><given-names initials="J">Jay</given-names></name><degrees>PhD</degrees><xref rid="A2" ref-type="aff">2</xref></contrib></contrib-group><aff id="A1"><label>1</label>Department of Physiotherapy, Federal University of Rio Grande do Norte, Natal, Brazil</aff><aff id="A2"><label>2</label>Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland, USA</aff><aff id="A3"><label>3</label>Departments of Medicine and Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland, USA</aff><aff id="A4"><label>4</label>Medical Care Clinical Center, VA Maryland Health Care System, Baltimore, Maryland, USA</aff><aff id="A5"><label>5</label>Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA</aff><aff id="A6"><label>6</label>Geriatric Research Education and Clinical Center, Veterans Affairs Maryland Healthcare System, Baltimore, Maryland, USA</aff><aff id="A7"><label>7</label>Division of Gerontology, Geriatrics, and Palliative Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA</aff><aff id="A8"><label>8</label>Division of Biostatistics and Bioinformatics, University of Maryland School of Medicine, Baltimore, Maryland, USA</aff><aff id="A9"><label>9</label>Department of Physical Therapy and Rehabilitation Science, University of Maryland School of Medicine, Baltimore, Maryland, USA</aff><author-notes><fn fn-type="con" id="FN1"><p id="P1">TWITTER:</p><p id="P2">Saionara M. A. C&#226;mara, Saionara_Aires</p></fn><fn fn-type="con" id="FN2"><p id="P3">AUTHOR CONTRIBUTIONS</p><p id="P4">SMAC, MCH, RM, DO, ALG, JG, LSM, and JM contributed to the design of the work. JM and DO obtained funding and contributed to the acquisition of data. SMAC and ZF contributed to data analysis. All authors contributed to interpretation of the results, were involved in the preparation and critical revision of the manuscript, and approved the version to be published.</p></fn><corresp id="CR1"><bold>Correspondence</bold>: Saionara M. A. C&#226;mara, Department of Physiotherapy, Federal University of Rio Grande do Norte, Campus Universit&#225;rio &#8211; Avenida Senador Salgado Filho, 3000, Lagoa Nova, CEP 59078&#8211;970, Natal, RN, Brazil. <email>saionara.aires@ufrn.br</email></corresp><fn fn-type="COI-statement" id="FN3"><p id="P45">CONFLICT OF INTEREST STATEMENT</p><p id="P46">RM is a full-time employee of Novartis Pharmaceuticals, and owns stock in Novartis Pharmaceuticals. MCH has performed consulting activities, including attendance at &#8220;virtual&#8221; Advisory Board meetings, for the following entities: Acadia Pharmaceuticals, Bioclinica, Eli Lilly, Dompe, Flexion Therapeutics Inc., Genascience, Gilead, GlaxoSmithKline, Kolon TissueGene, Novartis Pharma AG, Pfizer Inc., Regenosine, SFJ Pharmaceuticals Inc., Theralogix LLC, TrialSpark, WCG Analgesics Solutions, and Xalud Therapeutics, and was a member of Data Safety Monitoring Committees for clinical trials coordinated by ACI Clinical, Covance Inc., Cytel, Fortrea, ICON plc, IQVIA, JW Pharma, MiMedRx and PPD. MCH own stock and stock options in Estrato Pharma, Regenosine and Theralogix LLC. JM is on the boards of the Own the Bone Multidisciplinary Advisory Board of the American Orthopedics Association and of the Fragility Fracture Global Network.</p></fn></author-notes><pub-date pub-type="ppub"><month>9</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>12</day><month>6</month><year>2024</year></pub-date><volume>72</volume><issue>9</issue><issue-id pub-id-type="pmc-issue-id">484125</issue-id><fpage>2644</fpage><lpage>2655</lpage><pub-history><event event-type="nihms-submitted"><date><day>06</day><month>03</month><year>2025</year></date></event><event event-type="pmc-release"><date><day>13</day><month>03</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>13</day><month>03</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-03-14 10:25:42.027"><day>14</day><month>03</month><year>2025</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-2054154.pdf"/><abstract id="ABS1"><sec id="S1"><title>Background:</title><p id="P5">Persistent inflammation is associated with adverse health outcomes, but its impact on mortality has not been investigated previously among hip fracture patients. This article aims to investigate the influence of changes in levels of cytokines in the 2 months after a hip fracture repair on 5-year mortality.</p></sec><sec id="S2"><title>Methods:</title><p id="P6">This is a prospective cohort study from the Baltimore Hip Studies (BHS) with 191 community-dwelling older men and women (&#8805;65 years) who had recently undergone surgical repair of an acute hip fracture, with recruitment from May 2006 to June 2011. Plasma interleukin-6 (IL-6), soluble tumor necrosis factor alpha receptor1 (sTNF&#945;-R1), and interleukin-1 receptor agonist (IL-1RA) were obtained within 22 days of admission and at 2 months. All-cause mortality over 5 years was determined. Logistic regression analysis tested the associations between the cytokines&#8217; trajectories and mortality over 5 years, adjusted for covariates (age, sex, education, body mass index, lower extremity physical activities of daily living, and Charlson comorbidity index).</p></sec><sec id="S3"><title>Results:</title><p id="P7">High levels of IL-6 and sTNF&#945;-R1 at baseline with small or no decline at 2 months were associated with higher odds of 5-year mortality compared with those with lower levels at baseline and greater decline at 2 months after adjustment for age, and other potential confounders (OR = 4.71, <italic toggle="yes">p</italic> = 0.01 for IL-6; OR = 15.03, <italic toggle="yes">p</italic> = 0.002 for sTNF&#945;-R1). Similar results that failed to reach significance were found for IL-1RA (OR = 2.40, <italic toggle="yes">p</italic> = 0.18). Those with higher levels of cytokines at baseline with greater decline did not have significantly greater mortality than the reference group, those with lower levels at baseline and greater decline.</p></sec><sec id="S4"><title>Conclusion:</title><p id="P8">Persistent elevation of plasma IL-6 and sTNF&#945;-R1 levels within the first 2 months after hospital admission in patients with hip fracture is associated with higher 5-year mortality. These patients may benefit from enhanced care and earlier intensive interventions to reduce the risk of death.</p></sec></abstract><kwd-group><kwd>cytokine</kwd><kwd>fragility fractures</kwd><kwd>mortality</kwd><kwd>older adults</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>